Manufacturer of Controlled Substances; Notice of Application, 34162 [E6-9177]

Download as PDF 34162 Federal Register / Vol. 71, No. 113 / Tuesday, June 13, 2006 / Notices jlentini on PROD1PC65 with NOTICES water resources, groundwater resources, biological resources, selenium bioaccumulation, geology and seismicity, energy resources, air resources, agricultural production and economics, land use and soil resources, recreational resources, cultural resources, aesthetics, regional economics, and social issues and environmental justice. Reclamation determined that the action alternatives were unlikely to affect traffic and transportation, noise, utilities and public services, and Indian Trust Assets. Copies of the Final EIS are available for review and inspection at the following public libraries: • Bureau of Reclamation, Denver Office Library, Building 67, Room 167, Denver Federal Center, 6th and Kipling, Denver, CO 80225; telephone 303–445– 2072; • Bureau of Reclamation, Mid-Pacific Regional Library, 2800 Cottage Way, Sacramento, CA 95825; telephone 916– 978–5593; • Natural Resources Library, U.S. Department of the Interior, 1849 C Street, NW., Main Interior Building, Washington, DC 20240–0001; • Alameda County Public Library, 2450 Stevenson Boulevard, Fremont, CA 94538; telephone 510–745–1400; • Contra Costa County Library, 1750 Oak Park Boulevard, Pleasant Hill, CA 94523; telephone 925–646–6434; • Fresno County Public Library, 2420 Mariposa Street, Fresno, CA 93721; telephone 559–488–3195; • Kern County Public Library, 701 Truxton Avenue, Bakersfield, CA 93301; telephone 661–868–0701; • Kings County Public Library, 401 North Douty Street, Hanford, CA 93230; telephone 559–582–0261; • Merced County Public Library, 1312 South 7th Street, Los Banos, CA 95334; telephone 209–826–5254; • San Joaquin County Public Library, 605 North El Dorado Street, Stockton, CA 95334; telephone 209–937–8221; • San Luis Obispo County Public Library Bookmobile, PO Box 8107, San Luis Obispo, CA 93403; telephone for Bookmobile schedule/location 805– 788–2145; • Stanislaus County Public Library, 1500 I Street, Modesto, CA 95354; telephone 209–558–7800; • UC Berkeley Water Resources Center Archives, 410 O’Brien Hall, Berkeley, CA 94720; telephone 510– 642–2666. Additional Information Additional information is available online at https://www.usbr.gov/mp/ sccao/sld/. A Notice of Availability of the Draft EIS was VerDate Aug<31>2005 17:34 Jun 12, 2006 Jkt 208001 published in the Federal Register on June 2, 2005 (70 FR 32370). The Final EIS contains responses to all comments received and reflects comments and any additional information received during the review period. Reclamation’s practice is to make any communication related to proposed projects, including names and home addresses, available for public review. Individual respondents may request that we withhold their home address from public disclosure, which will be honored to the extent allowable by law. There may be circumstances in which a respondent’s identity may also be withheld from public disclosure, as allowable by law. If you wish to have your name and/or address withheld, you must state this prominently at the beginning of your communication. All submissions from organizations or businesses, and from individuals identifying themselves as representatives or officials of organizations or businesses, will be made available for public disclosure in their entirety. Susan L. Ramos, Assistant Regional Director, Mid-Pacific Region. [FR Doc. E6–9184 Filed 6–12–06; 8:45 am] BILLING CODE 4310–MN–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 18, 2005, Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedule II: Drug Schedule Amphetamine (1100) .................... Methylphenidate (1724) ................ Dextropropoxyphene, bulk (nondosage form) (9273). Phenylacetone (8501) .................. Fentanyl (9801) ............................ II II II II II The company plans to manufacture the listed controlled substances in bulk for sales to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance PO 00000 Frm 00111 Fmt 4703 Sfmt 4703 may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than August 14, 2006. Dated: June 7, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–9177 Filed 6–12–06; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule I or II and prior to issuing a regulation under 21 U.S.C. 952(a)(2)(B) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on January 26, 2006, Roche Diagnostics Operations, Inc., Attn: Regulatory Compliance, 9115 Hague Road, Indianapolis 46250, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in Schedule I & II: Drug Lysergic acid diethylamide (7315) Tetrahydrocannabinols (7370) ..... Cocaine (9041) ............................. Ecgonine (9180) ........................... Methadone (9250) ........................ Morphine (9300) ........................... Alphamethadol (9605) .................. Schedule I I II II II II II The company plans to import the listed controlled substances for the manufacture of diagnostic products for distribution to its customers. E:\FR\FM\13JNN1.SGM 13JNN1

Agencies

[Federal Register Volume 71, Number 113 (Tuesday, June 13, 2006)]
[Notices]
[Page 34162]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-9177]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on November 18, 2005, Cambrex 
Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed in Schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Dextropropoxyphene, bulk (non-dosage form)   II
 (9273).
Phenylacetone (8501).......................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for sales to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than August 14, 2006.

    Dated: June 7, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E6-9177 Filed 6-12-06; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.